The group�s principal activity is to harvest therapeutic human proteins from Lemna aquatic plant and species of flora through its LEX System and Plantibodies technologies. The group�s products include pipeline, controlled relief Alfa interferon and Alfa interferon. The group markets its products under the brand names Locteron(TM) and BLX-883. The group operates from the United States.
